Janux Therapeutics Statistics
Total Valuation
JANX has a market cap or net worth of $1.46 billion. The enterprise value is $484.66 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
JANX has 60.09 million shares outstanding. The number of shares has increased by 20.02% in one year.
Current Share Class | 60.09M |
Shares Outstanding | 60.09M |
Shares Change (YoY) | +20.02% |
Shares Change (QoQ) | +0.18% |
Owned by Insiders (%) | 6.55% |
Owned by Institutions (%) | 83.31% |
Float | 37.98M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3,322.28 |
Forward PS | 2,242.95 |
PB Ratio | 1.45 |
P/TBV Ratio | 1.47 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1,104.01 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 47.03, with a Debt / Equity ratio of 0.02.
Current Ratio | 47.03 |
Quick Ratio | 46.85 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -12.82% and return on invested capital (ROIC) is -10.69%.
Return on Equity (ROE) | -12.82% |
Return on Assets (ROA) | -10.51% |
Return on Invested Capital (ROIC) | -10.69% |
Return on Capital Employed (ROCE) | -14.33% |
Revenue Per Employee | $5,420 |
Profits Per Employee | -$1.30M |
Employee Count | 81 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.68% in the last 52 weeks. The beta is 2.85, so JANX's price volatility has been higher than the market average.
Beta (5Y) | 2.85 |
52-Week Price Change | -30.68% |
50-Day Moving Average | 24.70 |
200-Day Moving Average | 36.19 |
Relative Strength Index (RSI) | 54.16 |
Average Volume (20 Days) | 842,007 |
Short Selling Information
The latest short interest is 8.73 million, so 14.53% of the outstanding shares have been sold short.
Short Interest | 8.73M |
Short Previous Month | 9.65M |
Short % of Shares Out | 14.53% |
Short % of Float | 22.99% |
Short Ratio (days to cover) | 10.83 |
Income Statement
In the last 12 months, JANX had revenue of $439,000 and -$105.64 million in losses. Loss per share was -$1.80.
Revenue | 439,000 |
Gross Profit | -67.95M |
Operating Income | -144.88M |
Pretax Income | -44.05M |
Net Income | -105.64M |
EBITDA | -142.80M |
EBIT | -144.88M |
Loss Per Share | -$1.80 |
Full Income Statement Balance Sheet
The company has $996.01 million in cash and $22.19 million in debt, giving a net cash position of $973.82 million or $16.20 per share.
Cash & Cash Equivalents | 996.01M |
Total Debt | 22.19M |
Net Cash | 973.82M |
Net Cash Per Share | $16.20 |
Equity (Book Value) | 990.52M |
Book Value Per Share | 16.70 |
Working Capital | 984.17M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$59.79 million and capital expenditures -$911,000, giving a free cash flow of -$60.70 million.
Operating Cash Flow | -59.79M |
Capital Expenditures | -911,000 |
Free Cash Flow | -60.70M |
FCF Per Share | -$1.01 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -33,002.05% |
Pretax Margin | -24,064.01% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
JANX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -20.02% |
Shareholder Yield | -20.02% |
Earnings Yield | -7.24% |
FCF Yield | -4.16% |
Analyst Forecast
The average price target for JANX is $90.63, which is 263.83% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $90.63 |
Price Target Difference | 263.83% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | 98.97% |
EPS Growth Forecast (5Y) | -20.89% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
JANX has an Altman Z-Score of 32.26 and a Piotroski F-Score of 1.
Altman Z-Score | 32.26 |
Piotroski F-Score | 1 |